peerVue adds nine customers with launch of early adopter program

TriMed Staff | | Health Imaging | Practice Management
peerVue, a provider of niche healthcare software services, has begun its early adopter program with the addition of nine new customers.

The Burlington, Vt.-based peerVue said its program brings together healthcare organizations that share a commitment to quality improvement in radiology and communications in healthcare. The company said the program aims to link academic medical centers, community hospitals and imaging centers that are facing workflow and regulatory challenges.

The early adopter program includes: North Shore Long Island Jewish Hospital Health System, N.Y. (GE PACS); Radiology Imaging Associates, Colo. (Fuji, InteleRad and GE PACS); Mecklenburg Radiology Associates, N.C. (Neurostar and ImageCast PACS); Ohio Health, Ohio (Fuji PACS); Riverside Radiology Associates, Ohio (Fuji PACS); WakeMed Health & Hospitals, N.C. (Amicas PACS); Children’s Hospital Central California, Calif. (Amicas PACS); and Graham Hospital, Ill. (Amicas PACS).

TriMed Staff

Related Content

Warning: Sidelined reactor could trigger medical isotope shortage
Malpractice watchers: Radiologists, imaging societies should bone up on the ‘science of visual perception’
ACR shares guidance for radiology providers facing IV supply shortages after hurricane
Incidental finding characteristics that warrant communication
AI implementation improves when radiology staff concerns are considered
Hospital organization sees impressive returns from POCUS integration

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup